Applied Biologics activates first Phase 3 site for BIOxHEAL diabetic-ulcer trial
AI Summary- Applied Biologics activated the first clinical site for its BIOxHEAL Phase 3 trial.
- The study will compare BIOxHEAL plus standard care with standard care alone.
- Additional sites are advancing toward activation as patient screening and enrollment approach.